Cargando…

An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane

Human immunodeficiency virus type 1 (HIV-1) is characterized by high variability and drug resistance. This has necessitated the development of antivirals with a new chemotype and therapy. We previously identified an artificial peptide with non-native protein sequence, AP3, with the potential to inhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chao, Li, Qing, Sun, Lujia, Wang, Xinling, Wang, Huan, Zhang, Wenpeng, Li, Jiahui, Liu, Yang, Lu, Lu, Jiang, Shibo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223265/ https://www.ncbi.nlm.nih.gov/pubmed/37243126 http://dx.doi.org/10.3390/v15051038

Ejemplares similares

Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kinetics
por: De Feo, Christopher J, et al.
Publicado: (2014)

Evidence That the Transition of HIV-1 Gp41 into a Six-Helix Bundle, Not the Bundle Configuration, Induces Membrane Fusion
por: Melikyan, Grigory B., et al.
Publicado: (2000)

Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
por: Pu, Jing, et al.
Publicado: (2019)

Anti-HIV-1 activity of cellulose acetate phthalate: Synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles
por: Neurath, A Robert, et al.
Publicado: (2002)

Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket
por: Yu, Fei, et al.
Publicado: (2013)

An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen
por: Wang, Xinling, et al.
Publicado: (2023)

N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein
por: Qiu, Jiayin, et al.
Publicado: (2019)

An abiotic, tetrameric, eight-helix bundle
por: Menke, Friedericke S., et al.
Publicado: (2023)

The Conserved Residue Arg46 in the N-Terminal Heptad Repeat Domain of HIV-1 gp41 Is Critical for Viral Fusion and Entry
por: Wang, Xiaoyi, et al.
Publicado: (2012)

Six-helix bundle completion in the distal C-terminal heptad repeat region of gp41 is required for efficient human immunodeficiency virus type 1 infection
por: Liu, Dehua, et al.
Publicado: (2018)

Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection
por: Wang, Xinling, et al.
Publicado: (2021)

Bioorthogonal, Bifunctional Linker for Engineering Synthetic Glycoproteins
por: McBerney, Ryan, et al.
Publicado: (2022)

3-Hydroxyphthalic Anhydride- Modified Rabbit Anti-PAP IgG as a Potential Bifunctional HIV-1 Entry Inhibitor
por: Zhang, Xuanxuan, et al.
Publicado: (2018)

Lymphocyte integrins mediate entry and dysregulation of T cells by SARS-CoV-2
por: Huang, Mengwen, et al.
Publicado: (2023)

HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins
por: Falkenhagen, Alexander, et al.
Publicado: (2018)

A Toxin-Conjugated Recombinant Protein Targeting gp120 and gp41 for Inactivating HIV-1 Virions and Killing Latency-Reversing Agent-Reactivated Latent Cells
por: Wang, Xinling, et al.
Publicado: (2022)

Engineering a two-helix bundle protein for folding studies
por: Dodson, Charlotte A., et al.
Publicado: (2010)

A four-helix bundle stores copper for methane oxidation
por: Vita, Nicolas, et al.
Publicado: (2015)

CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease
por: Wendt, Emily, et al.
Publicado: (2015)

An engineered 5-helix bundle derived from SARS-CoV-2 S2 pre-binds sarbecoviral spike at both serological- and endosomal-pH to inhibit virus entry
por: Lin, Xi, et al.
Publicado: (2022)

Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
por: Wang, Lin, et al.
Publicado: (2020)

Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry
por: Berro, Reem, et al.
Publicado: (2009)

Unfolding and Folding of the Three-Helix Bundle Protein KIX in the Absence of Solvent
por: Schennach, Moritz, et al.
Publicado: (2016)

The Calcium-Dependent Switch Helix of L-Plastin Regulates Actin Bundling
por: Ishida, Hiroaki, et al.
Publicado: (2017)

System-Size Dependence of Helix-Bundle Formation for Generic Semiflexible Polymers
por: Williams, Matthew J., et al.
Publicado: (2016)

Rational thermostabilisation of four-helix bundle dimeric de novo proteins
por: Irumagawa, Shin, et al.
Publicado: (2021)

Thermostabilization mechanisms in thermophilic versus mesophilic three‐helix bundle proteins
por: Nguyen, Catrina, et al.
Publicado: (2021)

Permeation mechanisms through the selectivity filter and the open helix bundle crossing gate of GIRK2
por: Li, Dai-Lin, et al.
Publicado: (2020)

Theoretical insights on helix repacking as the origin of P-glycoprotein promiscuity
por: Bonito, Cátia A., et al.
Publicado: (2020)

Binding of HIV-1 gp41-Directed Neutralizing and Non-Neutralizing Fragment Antibody Binding Domain (Fab) and Single Chain Variable Fragment (ScFv) Antibodies to the Ectodomain of gp41 in the Pre-Hairpin and Six-Helix Bundle Conformations
por: Louis, John M., et al.
Publicado: (2014)

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein
por: Yu, Jingyou, et al.
Publicado: (2015)

SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread
por: Wang, Xinling, et al.
Publicado: (2023)

H Bonding at the Helix-Bundle Crossing Controls Gating in Kir Potassium Channels
por: Rapedius, Markus, et al.
Publicado: (2007)

Protein folding of the SAP domain, a naturally occurring two-helix bundle
por: Dodson, Charlotte A., et al.
Publicado: (2015)

CryoET structures of immature HIV Gag reveal six-helix bundle
por: Mendonça, Luiza, et al.
Publicado: (2021)

Helix Bundle Domain of Primase RepB′ Is Required for Dinucleotide Formation and Extension
por: Banchenko, Sofia, et al.
Publicado: (2021)

CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy
por: Grande, Fedora, et al.
Publicado: (2019)

Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein
por: Yang, Chan, et al.
Publicado: (2020)

Analysis of Determinants in Filovirus Glycoproteins Required for Tetherin Antagonism
por: Gnirß, Kerstin, et al.
Publicado: (2014)

Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism
por: Vande Burgt, Nathan H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fmcbn48b3kcd8uc6ipq1hdak61